Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease
Abstract Parkinson's disease (PD) is a progressive and chronic neurodegenerative disease of the central nervous system. Early treatment for PD is efficient; however, long-term systemic medication commonly leads to deleterious side-effects. Strategies that enable more selective drug delivery to...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/878f8f5c6a6f4583aee909721c20dc25 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:878f8f5c6a6f4583aee909721c20dc25 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:878f8f5c6a6f4583aee909721c20dc252021-12-02T16:24:56ZDopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease10.1038/s41598-021-94175-82045-2322https://doaj.org/article/878f8f5c6a6f4583aee909721c20dc252021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94175-8https://doaj.org/toc/2045-2322Abstract Parkinson's disease (PD) is a progressive and chronic neurodegenerative disease of the central nervous system. Early treatment for PD is efficient; however, long-term systemic medication commonly leads to deleterious side-effects. Strategies that enable more selective drug delivery to the brain using smaller dosages, while crossing the complex brain-blood barrier (BBB), are highly desirable to ensure treatment efficacy and decrease/avoid unwanted outcomes. Our goal was to design and test the neurotherapeutic potential of a forefront nanoparticle-based technology composed of albumin/PLGA nanosystems loaded with dopamine (ALNP-DA) in 6-OHDA PD mice model. ALNP-DA effectively crossed the BBB, replenishing dopamine at the nigrostriatal pathway, resulting in significant motor symptom improvement when compared to Lesioned and L-DOPA groups. Notably, ALNP-DA (20 mg/animal dose) additionally up-regulated and restored motor coordination, balance, and sensorimotor performance to non-lesioned (Sham) animal level. Overall, ALNPs represent an innovative, non-invasive nano-therapeutical strategy for PD, considering its efficacy to circumvent the BBB and ultimately deliver the drug of interest to the brain.Victoria Monge-FuentesAndréia Biolchi MayerMarcos Robalinho LimaLuiza Ribeiro GeraldesLarissa Nepomuceno ZanottoKarla Graziella MoreiraOlimpia Paschoal MartinsHenrique Luís PivaMaria Sueli Soares FelipeAndre Correa AmaralAnamélia Lorenzetti BoccaAntonio Claudio TedescoMárcia Renata MortariNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-16 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Victoria Monge-Fuentes Andréia Biolchi Mayer Marcos Robalinho Lima Luiza Ribeiro Geraldes Larissa Nepomuceno Zanotto Karla Graziella Moreira Olimpia Paschoal Martins Henrique Luís Piva Maria Sueli Soares Felipe Andre Correa Amaral Anamélia Lorenzetti Bocca Antonio Claudio Tedesco Márcia Renata Mortari Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease |
description |
Abstract Parkinson's disease (PD) is a progressive and chronic neurodegenerative disease of the central nervous system. Early treatment for PD is efficient; however, long-term systemic medication commonly leads to deleterious side-effects. Strategies that enable more selective drug delivery to the brain using smaller dosages, while crossing the complex brain-blood barrier (BBB), are highly desirable to ensure treatment efficacy and decrease/avoid unwanted outcomes. Our goal was to design and test the neurotherapeutic potential of a forefront nanoparticle-based technology composed of albumin/PLGA nanosystems loaded with dopamine (ALNP-DA) in 6-OHDA PD mice model. ALNP-DA effectively crossed the BBB, replenishing dopamine at the nigrostriatal pathway, resulting in significant motor symptom improvement when compared to Lesioned and L-DOPA groups. Notably, ALNP-DA (20 mg/animal dose) additionally up-regulated and restored motor coordination, balance, and sensorimotor performance to non-lesioned (Sham) animal level. Overall, ALNPs represent an innovative, non-invasive nano-therapeutical strategy for PD, considering its efficacy to circumvent the BBB and ultimately deliver the drug of interest to the brain. |
format |
article |
author |
Victoria Monge-Fuentes Andréia Biolchi Mayer Marcos Robalinho Lima Luiza Ribeiro Geraldes Larissa Nepomuceno Zanotto Karla Graziella Moreira Olimpia Paschoal Martins Henrique Luís Piva Maria Sueli Soares Felipe Andre Correa Amaral Anamélia Lorenzetti Bocca Antonio Claudio Tedesco Márcia Renata Mortari |
author_facet |
Victoria Monge-Fuentes Andréia Biolchi Mayer Marcos Robalinho Lima Luiza Ribeiro Geraldes Larissa Nepomuceno Zanotto Karla Graziella Moreira Olimpia Paschoal Martins Henrique Luís Piva Maria Sueli Soares Felipe Andre Correa Amaral Anamélia Lorenzetti Bocca Antonio Claudio Tedesco Márcia Renata Mortari |
author_sort |
Victoria Monge-Fuentes |
title |
Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease |
title_short |
Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease |
title_full |
Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease |
title_fullStr |
Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease |
title_full_unstemmed |
Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease |
title_sort |
dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for parkinson’s disease |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/878f8f5c6a6f4583aee909721c20dc25 |
work_keys_str_mv |
AT victoriamongefuentes dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT andreiabiolchimayer dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT marcosrobalinholima dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT luizaribeirogeraldes dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT larissanepomucenozanotto dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT karlagraziellamoreira dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT olimpiapaschoalmartins dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT henriqueluispiva dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT mariasuelisoaresfelipe dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT andrecorreaamaral dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT anamelialorenzettibocca dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT antonioclaudiotedesco dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease AT marciarenatamortari dopamineloadednanoparticlesystemscircumventthebloodbrainbarrierrestoringmotorfunctioninmousemodelforparkinsonsdisease |
_version_ |
1718384119561322496 |